To study the potential involvement of MDSCs in FAT1-mediated immunosuppression in tumors, we studied the expression of surrogate markers of MDSCs, namely, PD-L1, PD-L2, and IL-10 in gliomas. The gene discussed is PDCD1LG2; the disease is glioma.